Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-arylheteroarylalkyl imidazol-2-one compounds for treatment of arteriosclerosis

N-arylheteroarylalkyl imidazol-2-one compounds for treatment of arteriosclerosis

US Patent 6492397 · Granted Dec 10, 2002

Estimated economic value: $104,261,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrazoline compounds2010
Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antag2006
Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antag2006
Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inh2006
3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents2006
Combination therapy employing ileal bile acid transport inhibiting benzothiepine2005
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhi2005
Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides2005
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory di2005
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory di2005
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibi2004
Benzothiepines having activity as inhibitors of ileal bile acid transport and ta2004